Mixed Deck — All PEBC Topics Flashcards

Which evidence-based approach is most important when applying treatment planning principles?

Answer: Integrating current research with clinical expertise and patient values

Evidence-based practice in ${subj.toLowerCase()} requires integrating current research findings with clinical expertise and individual patient values.

Which phase I metabolic reaction is most commonly catalyzed by cytochrome P450 enzymes?

Answer: Oxidation

Oxidation is the predominant phase I reaction and is primarily carried out by cytochrome P450 (CYP) enzymes located mainly in the liver.

In the context of clinical assessment, the term 'sentinel symptom' refers to:

Answer: A symptom requiring urgent referral due to potential serious pathology

Sentinel (or 'red flag') symptoms signal potentially serious conditions requiring urgent medical evaluation rather than self-care.

Which ethical principle is most directly applicable to documentation standards?

Answer: Beneficence — acting in the patient's best interest

Beneficence, the principle of acting in the patient's best interest, is fundamental to ethical practice in documentation standards.

What format is used for the PEBC Qualifying Examination Part II?

Answer: Objective Structured Clinical Examination (OSCE)

QE Part II uses the OSCE format, where candidates rotate through stations demonstrating clinical and communication skills in simulated practice scenarios.

The PEBC Qualifying Examination Part I includes both operational (scored) items and pilot (pretest) items. Which of the following statements about pilot items is MOST accurate in the context of the QE Part I administration?

Answer: Pilot items are embedded throughout the exam and are indistinguishable from operational items; they do not count toward the candidate's score but are used to evaluate item psychometric properties for future administrations

Pilot items are embedded within the operational exam and are completely indistinguishable from scored items — candidates cannot identify which questions are being piloted. These unscored items allow PEBC to gather psychometric data (difficulty, discrimination, differential item functioning) on new questions before promoting them to operational status. Candidates should treat every item as if it is scored. The number of pilot items embedded in any given administration is not publicly disclosed, which is a deliberate design choice to prevent strategic test-taking.

A patient asks about a competitor pharmacy's lower drug price. What is the MOST professional response?

Answer: Acknowledge the concern, explain your pharmacy's value, and offer to check available options

Acknowledging the patient's concern and explaining value demonstrates professionalism and respects patient autonomy.

When using the PEBC Practice Analysis as a preparation resource, what is its PRIMARY intended use for candidates, and what is a key limitation that is often misunderstood?

Answer: It identifies the frequency and criticality of real-world pharmacist tasks to guide study prioritization, but it does NOT specify which drug classes or therapeutic areas will appear on the exam

The PEBC Practice Analysis surveys practising pharmacists to determine which tasks are most frequent and critical in real-world practice, and this analysis informs the exam blueprint. However, candidates often misunderstand it as a drug-list or question bank — it does not enumerate specific therapeutic areas or drug classes, nor does it contain practice questions. It is a structural document for understanding what competency domains matter most.

A clinical pharmacist is assessing nutritional status in an ICU patient using the Subjective Global Assessment (SGA). The patient has lost 12% of body weight over 3 months, has mild ankle edema, and diminished subcutaneous fat over the triceps with moderate muscle wasting at the temples. Dietary intake has been inadequate for 3 weeks. Based on SGA methodology, which rating is MOST appropriate?

Answer: SGA-B (moderately malnourished or suspected malnutrition) based on functional and physical findings

SGA-B (moderately/suspected malnourished) is appropriate here. SGA integrates weight change, dietary intake, GI symptoms, functional capacity, and physical exam findings (subcutaneous fat, muscle wasting, edema). Weight loss of 12% over 3 months is significant, but the physical findings (mild, not severe muscle wasting; diminished but not absent subcutaneous fat) and edema do not meet the threshold for SGA-C. SGA-C requires severe losses across multiple domains. Importantly, SGA does NOT use a single cutoff (e.g., >10% weight loss) to assign a category — it is a composite clinical judgment. While NUTRIC scores are used in ICU for nutrition risk, SGA remains applicable in this setting.

A patient using motivational interviewing (MI) language says: 'I know I should probably cut back on the drinking, but it helps me sleep.' This statement BEST exemplifies which MI concept, and what is the pharmacist's MOST therapeutic response?

Answer: Ambivalence; reflect both sides of the patient's statement before exploring the 'change talk' component.

The statement is a classic expression of ambivalence — the patient acknowledges a reason to change ('I should probably') while voicing a perceived benefit of the behavior ('helps me sleep'). In MI, ambivalence is normalized and explored, not confronted. A double-sided reflection ('On one hand… and on the other…') honors both sides and keeps the patient engaged. Confronting or redirecting immediately triggers reactance and breaks therapeutic alliance. Discord, a distinct concept, refers to friction between patient and clinician, which is not evident here.

Which receptor type directly opens an ion channel upon ligand binding?

Answer: Ionotropic receptor

Ionotropic receptors (ligand-gated ion channels) directly gate ion channels when a ligand binds, producing rapid effects.

A pharmacist is preparing a compounded sterile preparation (CSP) classified as Category 2 under USP . The beyond-use date (BUD) assigned is 45 days refrigerated. Which of the following conditions MUST be met to support this BUD?

Answer: The preparation must pass sterility testing and bacterial endotoxin testing (BET) before release

Under USP , Category 2 CSPs that are assigned extended BUDs (beyond the default Category 1 limits of 12 hours at room temperature or 24 hours refrigerated) require sterility testing and bacterial endotoxin testing (BET) before patient administration. These tests are mandatory to justify the extended BUD assignment. Preparation in an ISO 5 environment is required for all sterile compounding but alone does not justify extended BUDs without testing.

A hospital pharmacist receives an institutional directive to perform automatic generic substitution for all brand-name cardiovascular medications to reduce formulary costs, without requiring individual prescriber notification. For one patient on a narrow-therapeutic-index drug (digoxin), the pharmacist has clinical concerns that the specific generic's bioavailability profile differs meaningfully from the brand. Management insists the policy applies uniformly. What is the pharmacist's primary obligation?

Answer: Notify the prescribing physician of the substitution and the specific clinical concern before dispensing, as the fiduciary duty and standard of practice require pharmacist judgment on therapeutic equivalence for narrow-therapeutic-index drugs

Pharmacists bear an independent professional and fiduciary duty to each patient — this duty cannot be delegated to institutional policy. For narrow-therapeutic-index drugs like digoxin, automatic substitution carries documented risks of toxicity or subtherapeutic levels due to inter-product bioavailability variation. Canadian pharmacy standards of practice (e.g., NAPRA Model Standards) require pharmacists to exercise clinical judgment on therapeutic appropriateness and to communicate clinically significant concerns to prescribers. Institutional cost policies do not override this duty. Filing an incident report (B) is insufficient if the pharmacist proceeds with a clinically questionable substitution without prescriber awareness. Reporting to the college (D) may be appropriate later but is not the immediate obligation.

What does the Swiss Cheese Model of accident causation illustrate in the context of pharmacy safety?

Answer: That multiple layers of defenses each have weaknesses, and errors occur when holes align

The Swiss Cheese Model shows that harm occurs only when the gaps (holes) in multiple independent safety barriers align simultaneously, emphasizing layered defenses.

A candidate passes the PEBC Evaluating Examination. How long does a passing EE result remain valid for the purpose of registering for QE Part I?

Answer: The passing result has no expiry and remains valid indefinitely

As per PEBC policy, a passing score on the Evaluating Examination does not expire. Candidates who pass the EE retain that eligibility and may proceed to QE Part I registration without concern for a validity window. This is a frequently misunderstood point, as many candidates assume time limits apply by analogy with other licensing examinations.

A pharmacist reads a study that found a new statin reduced cardiovascular events with an NNT of 200 over 5 years. How should this value be interpreted?

Answer: 200 patients must be treated for 5 years to prevent one cardiovascular event

NNT (Number Needed to Treat) is the number of patients who must receive the treatment over the specified period to prevent one additional outcome event. NNT = 1/ARR. An NNT of 200 means treating 200 patients for 5 years prevents one event.

During therapeutic drug monitoring (TDM) of vancomycin using AUC-guided dosing, a patient's calculated AUC₀₋₂₄ is 520 mg·h/L. The current regimen is 1250 mg IV q12h. The MIC of the isolated MRSA strain is 1 mg/L. Which is the most pharmacodynamically appropriate interpretation?

Answer: The regimen is supratherapeutic; dose reduction is warranted to minimize nephrotoxicity risk while maintaining efficacy

Current ASHP/IDSA/SIDP guidelines recommend an AUC/MIC target of 400–600 mg·h/L for serious MRSA infections. An AUC₀₋₂₄ of 520 mg·h/L with an MIC of 1 mg/L yields an AUC/MIC of 520, which falls within the therapeutic window. However, values above 600 are associated with significantly increased nephrotoxicity without additional efficacy gain. At 520 the patient is within range but approaching the upper limit — the regimen is currently acceptable but the prescriber should monitor renal function closely; dose reduction is not yet warranted. The most precise interpretation is that the regimen is within target, making option A the closest, but option B reflects the nuanced clinical concern. Re-reading: AUC/MIC = 520/1 = 520, which IS within 400–600 — option A states it correctly. Option B recommends unnecessary dose reduction. The correct answer is A.

A pharmacist is assessing a patient's medication adherence. The patient reports taking their antihypertensive medications only 3–4 days per week. What is the MOST appropriate first intervention?

Answer: Explore barriers to adherence through motivational interviewing before modifying the regimen

Identifying and addressing patient-specific barriers through motivational interviewing is the foundational first step before making any therapeutic changes.

A pharmacy technician candidate passes the PEBC Pharmacy Technician Qualifying Examination (PTQE) written component but fails the OSPE component on the first attempt. What is the most accurate statement about their re-examination options?

Answer: They may retake only the OSPE component, as the written result is banked for a defined period per PEBC policy.

PEBC allows candidates who pass one component of the PTQE to bank that result and retake only the failed component within the eligibility window. This policy prevents candidates from having to repeat work they have already demonstrated competency in. The 12-month waiting period and permanent bar scenarios are incorrect, and there is no provincial override for PEBC examination components.

A pharmacist discovers a dispensing error made by a colleague that did not harm the patient. What is the most appropriate action?

Answer: Report it to the pharmacy manager and document it per incident reporting policy

Near-miss errors must be reported internally and documented to improve systems and prevent future harm.